Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
$37.58
+0.3%
$35.41
$29.19
$37.64
$1.04B0.72114,639 shs50,651 shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$17.91
-2.5%
$27.18
$16.72
$44.33
$369.24M0.83259,314 shs243,413 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
+0.35%+1.16%+7.10%+21.19%+13.19%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-2.48%+4.59%-36.14%-30.28%-55.11%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
3.5677 of 5 stars
3.53.00.00.01.13.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
2.55
Moderate Buy$37.58N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
3.00
Buy$41.25130.38% Upside

Current Analyst Ratings Breakdown

Latest GEM, SLP, EEE, and NTVO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
6/13/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$45.00 ➝ $36.00
6/3/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/16/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$32.00 ➝ $40.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
N/AN/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$70.01M5.14$0.75 per share23.93$9.12 per share1.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
N/AN/A13.33N/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$9.95M$0.3551.1614.21N/A9.18%7.86%7.35%7/14/2025 (Estimated)

Latest GEM, SLP, EEE, and NTVO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/14/2025Q3 2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.29N/AN/AN/A$22.83 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
$0.822.18%N/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
N/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
4.37
4.37

Institutional Ownership

CompanyInstitutional Ownership
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%

Insider Ownership

CompanyInsider Ownership
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo
GEM
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
N/A27.65 millionN/ANot Optionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
16020.11 million16.21 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock logo

Goldman Sachs ActiveBeta Emerging Markets Equity ETF NYSEARCA:GEM

$37.58 +0.13 (+0.35%)
As of 07/3/2025 05:00 PM Eastern

The Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of emerging market stocks comprising 4 sub-indexes: value, momentum, quality, and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight. GEM was launched on Sep 29, 2015 and is managed by Goldman Sachs.

Simulations Plus stock logo

Simulations Plus NASDAQ:SLP

$17.90 -0.46 (-2.48%)
Closing price 07/3/2025 03:33 PM Eastern
Extended Trading
$17.79 -0.12 (-0.64%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.